|
Targeted drug delivery can focus treatment on the region of the body affected by a given pathology thereby enhancing the effectiveness of the treatment while reducing side effects inherent in systemic treatments. Towards that end, we are leveraging the ion conductivity of polymers to develop implantable devices that can deliver drugs precisely when and where they are needed. We showed this to be a promising strategy for managing epileptic seizures. We are currently testing the efficacy of this approach for treating pathologies such as brain tumours and Parkinson’s disease. |
